Company news: Avecho; Bioxyne; Elixinol Wellness; IDT Australia; Melodiol Global Health; Zelira by Steve Jones July 31, 2024November 25, 2024 Avecho Biotechnology is continuing to run its phase III clinical trial as it seeks to register […]
Financial results: Bioxyne; Rua Bioscience; Bod Science; Avecho; Wellnex Life; MGC Pharma; Cannasouth by Steve Jones March 7, 2024March 7, 2024
Quarterly results: Avecho; Melodiol; Bioxyne/BLS; Emyria; Ecofibre; Zelira; Elixinol; AusCann; Botanix by Steve Jones and Martin Lane January 31, 2024July 11, 2024
Financial results: Avecho; Wellnex; Zelira; Emyria; Botanix; MGC Pharma; AusCann; Epsilon; Melodiol; Bioxyne by Martin Lane and Steve Jones September 4, 2023April 30, 2024
Avecho raises another A$6m to fund trial as firm enters ‘defining chapter’ by Steve Jones August 28, 2023April 30, 2024
Avecho looks to Authorised Prescribers to find optimal dose for new fast-onset THC gummies by Steve Jones August 9, 2023August 21, 2023
Avecho completes development of fast-onset CBD gummy product by Martin Lane June 14, 2023April 30, 2024
